The asset, dubbed NRTX-1001, is currently being tested in an open-label phase 1/2 trial among patients with drug-resistant mesial temporal lobe epilepsy (MTLE), plus another phase 1/2 study for ...

Deep learning–based reconstruction (DLR) significantly improved image quality in temporal bone ultrahigh-resolution CT (UHR-CT) for both adult and paediatric protocols, reducing noise and ...

In lieu of flowers, donations in Carey’s memory to Xavier High School, 181 Randolph Road, Middletown, CT 06457 or National Multiple Sclerosis CT Chapter, 659 Tower Avenue First Floor ...

an investigational allogeneic inhibitory neuron cell therapy candidate that is being developed for treatment of drug-resistant mesial temporal lobe epilepsy (MTLE). The data will be presented at ...

CT results were matched with patients’ data ... hippocampal sclerosis; cysticercosis; temporal lobe epilepsy; mesial temporal sclerosis; neurocysticercosis; calcifications Estudos recentes têm ...

An axial image of the head obtained on 18 F-fluorodeoxyglucose positron-emission tomography (Panel B) shows subtle hypometabolism in the left mesial temporal lobe (arrow). The patient’s baseline ...

today announced that the first patient has been dosed in the GenTLE Phase I/IIa clinical trial of AMT-260 for the treatment of refractory mesial temporal lobe epilepsy (MTLE). “The dosing of the ...

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia ... due to the degeneration of neurons in the frontal and temporal lobes. Hollywood action star Bruce Willis announced his ...

Figure 3. (A) CT-scan showing a single calcification (black arrow) highly suggestive of cNCC. (B) MRI FLAIR coronal imaging showing findings of hippocampal sclerosis (white arrow), typically observed ...

SAN FRANCISCO, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological ...

Researchers from The Brigham and Women's Hospital presented data from a study that aimed to evaluate the role of somatic variants in drug-resistant mesial temporal lobe epilepsy (MTLE). High-coverage ...